Abiopharma

News list

GUGGENHIME ANDREW 🔴 sold 2.7K shares of Vaxcyte, Inc. (PCVX) at $61.58 Transaction Date: Aug 31, 2026 | Filing ID: 000016

Full text

News bot Sept. 2, 2026, 11:57 p.m.
🔍 GUGGENHIME ANDREW (Executive)

Company: Vaxcyte, Inc. (PCVX)

Report Date: 2026-08-31
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 2,705
- Total shares held: 61,850
Detailed Transactions and Holdings:
- Sold 1,273 shares of Common Stock at $60.74 per share (Direct)
  Date: 2026-08-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 103,903.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 1,432 shares of Common Stock at $61.58 per share (Direct)
  Date: 2026-09-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 102,471.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 61,850.00 | Footnotes: F2
Footnotes:
- F1: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
- F2: Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the annuitant and the trustee.